First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer.
- Resource Type
- Article
- Authors
- Yeh, Randy; O'Donoghue, Joseph A.; Jayaprakasam, Vetri Sudar; Mauguen, Audrey; Min, Ryan; Park, Sue; Brockway, Julia P.; Bromberg, Jacqueline F.; Zhi, W. Iris; Robson, Mark E.; Sanford, Rachel; Modi, Shanu; Agnew, Brian J.; Lyashchenko, Serge K.; Lewis, Jason S.; Ulaner, Gary A.; Zeglis, Brian M.
- Source
- Journal of Nuclear Medicine; Mar2024, Vol. 65 Issue 3, p386-393, 8p
- Subject
- Language
- ISSN
- 01615505